Precision Therapeutics’ Subsidiary Helomics and National Alopecia Areata Foundation Sign Services Agreement to Provide Next-Generation Patient Registry for Alopecia Areata Research

    NEXT STORY
    Global Genital Herpes Treatment Drugs Market Study, 2019: Excellent Product Pipeline Catering Therapeutics Vaccines to Bolster Patient Immunity Such as GEN-003 and VCL-HB01
    PREV STORY
    Corbus Pharmaceuticals Announces Change of Primary Endpoint in Ongoing RESOLVE-1 Phase 3 Study in Systemic Sclerosis in U.S. to ACR CRISS from mRSS Following Meeting with FDA
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Diet Doc Announces Their All-Inclusive, Nationwide Medical Weight Loss Service that Enables Dieters Throughout the Country to Connect with the Best Minds in the Business for Safe and Fast Weight Loss

    LOS ANGELES, Dec. 30, 2015 (GLOBE NEWSWIRE) -- For many Americans, finding a doctor ...

    author_avatar
    NASDAQ Market News

    Sorrento Therapeutics Announces Discovery of a Potential Non-Dopaminergic Approach to Controlling Parkinson’s Motor Symptoms With Resiniferatoxin (RTX) Intrathecal Administration

    author_avatar
    NASDAQ Market News

    Sun BioPharma Announces Completion of the Second Patient Cohort and Starts Recruitment of Third Cohort Patients in the Dose Escalation Phase 1 Study of SBP101 for Pancreatic Cancer

    MINNEAPOLIS, Aug. 15, 2016 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCPink:SNBP), a biopharmaceutical company ...

    author_avatar
    NASDAQ Market News